{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:15:22Z","timestamp":1791645322680,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ejphar.2011.07.016","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T04:41:12Z","timestamp":1312260072000},"page":"497-506","source":"Crossref","is-referenced-by-count":48,"title":["Effect of treatment of high fat fed\/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications"],"prefix":"10.1016","volume":"668","author":[{"given":"Eric P.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Coppey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amey","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Yorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.07.016_bb0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bcp.2009.05.018","article-title":"The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality","volume":"78","author":"Abassi","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.HYP.0000225402.69580.1d","article-title":"Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice","volume":"48","author":"Araki","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0015","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.bjp.0703442","article-title":"Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats","volume":"130","author":"Arbin","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjp.0704098","article-title":"Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor on insulin sensitivity in obese Zucker rat","volume":"133","author":"Arbin","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clpt.2005.09.011","article-title":"Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans","volume":"79","author":"Azizi","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0030","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/tx9501445","article-title":"Oxidative damage and tyrosine nitration from peroxynitrite","volume":"9","author":"Beckman","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.acthis.2007.12.004","article-title":"Epidermal nerve fiber quantification in the assessment of diabetic neuropathy","volume":"110","author":"Beiswenger","year":"2008","journal-title":"Acta Histochem."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0040","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1152\/ajpendo.00481.2007","article-title":"Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle","volume":"294","author":"Bouskila","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1471-4159.2005.03584.x","article-title":"Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibers of inclusion body myositis","volume":"96","author":"Broccolini","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0050","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.hrthm.2005.05.016","article-title":"Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure","volume":"2","author":"Cha","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1155\/EDR.2000.131","article-title":"Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that provide circulation to the sciatic nerve","volume":"1","author":"Coppey","year":"2000","journal-title":"Int. J. Exp. Diabetes Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0704216","article-title":"Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular function of epineurial arterioles of the sciatic nerve","volume":"134","author":"Coppey","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0065","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/diabetes.50.8.1927","article-title":"Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve","volume":"50","author":"Coppey","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/15604280212525","article-title":"Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve","volume":"3","author":"Coppey","year":"2002","journal-title":"Int. J. Exp. Diabetes Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/diabetes.55.02.06.db05-0885","article-title":"ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats","volume":"55","author":"Coppey","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/db06-1180","article-title":"Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor, on vascular and neural disease","volume":"56","author":"Davidson","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0085","doi-asserted-by":"crossref","first-page":"91237","DOI":"10.1155\/2009\/912327","article-title":"Vascular and neural dysfunction in obese Zucker rats: effect of AVE7688","volume":"2009","author":"Davidson","year":"2009","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/dmrr.1088","article-title":"Diet induced obesity in Sprague Dawley rats causes microvascular and neural dysfunction","volume":"26","author":"Davidson","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1745-7254.2005.00090.x","article-title":"Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats","volume":"26","author":"Ding","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"228\u2013233","key":"10.1016\/j.ejphar.2011.07.016_bb0100","first-page":"2003","article-title":"Neutral endopeptidase expression in mesangial cells","volume":"4","author":"Ebihara","year":"2003","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000028304","article-title":"Distribution of neutral endopeptidase activity along the rat and rabbit nephron","volume":"59","author":"Edwards","year":"1999","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0895-7061(02)02268-9","article-title":"Effects of omapatrilat on the renin\u2013angiotensin system in salt-sensitive hypertension","volume":"15","author":"Ferrario","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0115","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/diabetes.32.11.988","article-title":"Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy","volume":"32","author":"Finegold","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0120","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.phrs.2007.01.015","article-title":"PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance","volume":"55","author":"Gaikwad","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(98)00038-7","article-title":"Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels","volume":"345","author":"Gonzalez","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0026-0495(95)90276-7","article-title":"Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats","volume":"44","author":"Henriksen","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0140","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/diab.45.1.S125","article-title":"Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism","volume":"45","author":"Henriksen","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0145","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1073\/pnas.0802690105","article-title":"Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose tolerance","volume":"105","author":"Jayasooriya","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.placenta.2003.09.002","article-title":"Signal pathway involved in increased expression of neutral endopeptidase by gonadotropin releasing hormone in choriocarcinoma cells","volume":"25","author":"Kikkawa","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0155","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1210\/en.2005-0003","article-title":"Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor","volume":"146","author":"Kouyama","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0160","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0140-6736(98)02478-7","article-title":"Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomized double-blind controlled trial","volume":"352","author":"Malik","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0165","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/db09-0393","article-title":"Natriuretic peptides\/cGMP\/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity","volume":"58","author":"Miyashita","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.shk.0000055815.40894.16","article-title":"Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells","volume":"19","author":"Muangman","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0175","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0026-0495(99)90263-9","article-title":"Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance","volume":"48","author":"Nawano","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0180","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diabetes.53.3.711","article-title":"Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy","volume":"53","author":"Obrosova","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0190","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1152\/ajpendo.00594.2004","article-title":"Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty (ZDF) and Zucker rats","volume":"289","author":"Oltman","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/oby.2007.19","article-title":"Attenuation of vascular\/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin","volume":"16","author":"Oltman","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1463-1326.2008.00924.x","article-title":"Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction","volume":"11","author":"Oltman","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0205","first-page":"L699","article-title":"The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide","volume":"268","author":"Pryor","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0895-7061(01)02157-4","article-title":"Effect of ACE\/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats","volume":"14","author":"Pu","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0215","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1681\/ASN.V12112280","article-title":"Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension","volume":"12","author":"Quaschning","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0220","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1053\/meta.2000.17721","article-title":"A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat","volume":"49","author":"Reed","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-5491.1995.tb00482.x","article-title":"Is ACE inhibition with lisinopril helpful in diabetic neuropathy?","volume":"12","author":"Reja","year":"1995","journal-title":"Diabetes Med."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0230","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00005344-200408000-00016","article-title":"Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat","volume":"44","author":"Russell","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.intimp.2007.07.021","article-title":"Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats","volume":"8","author":"Santos","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0240","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bcp.2009.06.018","article-title":"Long term treatment with ACE inhibitor enalapril decreases body weight gain and increased life span in rats","volume":"78","author":"Santos","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0008-6363(03)00544-3","article-title":"Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats","volume":"60","author":"Schafer","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00125-003-1264-8","article-title":"The vasopeptidase inhibitor AVE7688 ameliorates type 2 diabetic nephropathy","volume":"47","author":"Schafer","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.bjp.0705884","article-title":"Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent","volume":"143","author":"Schafer","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0260","doi-asserted-by":"crossref","first-page":"48066","DOI":"10.1074\/jbc.M204058200","article-title":"Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity","volume":"277","author":"Schling","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0270","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/HJH.0b013e3282f9b58a","article-title":"Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway","volume":"26","author":"Sugimoto","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0275","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/plac.2002.0820","article-title":"Neutral endopeptidase\/CD10 expression during phorbol ester-induced differentiation of choriocarcinoma cells through the protein kinase C- and extracellular signal-regulated kinase-dependent signaling pathway","volume":"23","author":"Suzki","year":"2002","journal-title":"Placenta"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0280","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.V12102051","article-title":"Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone","volume":"12","author":"Taal","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0285","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/00005344-199800001-00021","article-title":"Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors","volume":"31","author":"Vatter","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0290","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.CIR.0000062646.09566.CC","article-title":"Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0295","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.07.027","article-title":"Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin","volume":"620","author":"Wang","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0300","first-page":"99","article-title":"Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus","volume":"40","author":"Wang","year":"2011","journal-title":"Wei Sheng Yan Jiu"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0305","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fasebj.14.2.271","article-title":"Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders","volume":"14","author":"Wattanapitayakul","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0310","doi-asserted-by":"crossref","first-page":"139S","DOI":"10.1016\/S0895-7061(99)00205-8","article-title":"Emerging treatments for hypertension: potential role for vasopeptidase inhibition","volume":"12","author":"Weber","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0315","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.physbeh.2009.05.009","article-title":"Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL\/6J mice maintained on a high fat diet","volume":"98","author":"Weisinger","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0320","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1677\/joe.1.06396","article-title":"Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase","volume":"190","author":"Wong","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/138945008783431736","article-title":"The potential role of angiotensin converting enzyme and vasopeptidase inhibitors in the treatment of diabetic neuropathy","volume":"9","author":"Yorek","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2011.07.016_bb0330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15438600490486732","article-title":"Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes","volume":"5","author":"Yorek","year":"2004","journal-title":"Exp. Diabesity Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0335","article-title":"The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model","volume":"704045","author":"Zhang","year":"2008","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.ejphar.2011.07.016_bb0340","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.nut.2010.01.011","article-title":"Beneficial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes","volume":"26","author":"Zhu","year":"2010","journal-title":"Nutrition"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911007916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911007916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T09:47:18Z","timestamp":1638179238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911007916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0014299911007916"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.07.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}